We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Non-Tech : Metabolix [MBLX] a Full Disclosure Thread

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Sam Citron who wrote (65)3/6/2009 8:09:32 AM
From: Glenn Petersen  Read Replies (1) of 78
[t]MBLX[/t] has been cut in half since that article was published.

A few observations:

-- The company has not yet filed its 10-K. According to the third quarter 10-Q, Tellas, the joint-venture with Archer Daniels Midland, will start producing commercial quantities of Mirel during the second quarter of 2009. As of September 30, the company had $94.6 million in cash and short-term investments on hand, offset by $29 million in deferred revenues (advances from ADM). The company is losing about $10 million per quarter.

-- According to the analysts surveyed by Yahoo, the company will generate revenues of $24.8 million this year (up from an estimated $1.9 million in 2008) and lose $1.58 per share.

-- The decline in oil prices has removed their cost advantage.

Hoping for $4 or lower.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext